Caring for Transgender Individuals at Risk of Thrombosis

July 31, 2019

This is a recorded version of the webinar on Caring for Transgender Individuals at Risk of Thrombosis that was presented live on July 31, 2019. Please scroll all the way down this page to view the archived webinar. 

Webinar Launch Date: 7/31/19
Estimated Time to complete: 1 hour
Format: Archived Webinar
Target Audience: Primary Care Physicians, Specialty Physicians (Ob/Gyn, Oncology, Hematology), Physician Assistants, Advanced Nurse Practitioners, Registered Nurses, Licensed Practical Nurses, Registered Nurses in Specialty Areas (Ob/Gyn, Oncology, Hematology)

Program Description: 
This state-of-the-science Webinar will focus on the care of transgender individuals, highlighting specific issues and needs that these individuals may have. The faculty will address thrombotic risks associated with hormones in cis- and transgender women when used for therapy or replacement, including gender-affirming hormone therapy for transgender individuals; the medical and treatment strategies that are in use and recommended; and the necessary collaboration between disciplines for its effective management and treatment.

Learning Objectives:

After completing this educational activity, participants should be able to:


Joshua D. Safer, MD, FACP, FACE
Executive Director, Center for Transgender Medicine and Surgery
Mount Sinai Health System
Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, NY

Barbara A. Konkle, MD
Associate Chief Scientific Officer 
Associate Director, Washington Center for Bleeding Disorders
Director, Hemostasis, Platelet Immunology, and Genomics Laboratory
Bloodworks Northwest
Professor of Medicine/Hematology, University of Washington 
Seattle, WA